HH Sheikh Sultan Bin Khalifa Al Nahyan Humanitarian & Scientific Foundation and Burjeel Medical City Collaborate

Abu Dhabi: In the presence of H.H. Dr. Sheikh Sultan Bin Khalifa Al Nahyan, Advisor for the President of the United Arab Emirates and Chief Patron of the Foundation, the HH Sultan bin Khalifa Al Nahyan Humanitarian & Scientific Foundation and Burjeel Medical City, a subsidiary of VPS Healthcare Group, signed a Memorandum of Understanding  to strengthen their partnership within the subject of healthcare; notably for administration of sufferers with thalassemia who usually have to journey exterior the UAE to learn from advances in care. In addition to serving to meet the continual care wants of thalassemia sufferers inside the nation, the cooperation will additional contribute to supporting and growing scientific analysis packages that tackle persisting unmet wants.  

The signing was attended by Dr. Shamsheer Vayalil, Chairman and Managing Director of VPS Healthcare, with the settlement being signed by Dr. Mahmoud Taleb Al Ali, CEO of the HH Sultan Bin Khalifa Al Nahyan Humanitarian & Scientific Foundation, and Mr. John Sunil, Regional CEO of Burjeel Hospitals, within the presence of a number of members of the Foundation in addition to docs and executives from VPS Healthcare. 

Under the settlement, the Foundation will refer thalassemia sufferers to Burjeel Medical City for his or her routine administration wants, because the establishment presents state-of-the-art therapy amenities together with bone marrow transplantation. 

The settlement additional revolves round optimizing the scientific care pathway for thalassemia sufferers within the UAE, along with offering complete care providers outfitted with the most recent diagnostic and administration experience, in addition to engagement in novel remedy scientific trials aiming to handle scientific unmet wants and enhance affected person outcomes. The cooperation may even embody growth of thalassemia consciousness and academic campaigns and sources for all stakeholders concerned within the care of sufferers with thalassemia; and will revisit and improve affected person and household experiences via built-in and superior options. 

As a humanitarian and scientific establishment, the HH Sultan Bin Khalifa Al Nahyan Humanitarian & Scientific Foundation is dedicated to bettering entry to medical therapy and care, fostering developments in schooling and scientific analysis, and supporting humanitarian and charitable providers.  

Dr. Mahmoud Taleb Al Ali, CEO of the Foundation, welcomed the signing of the brand new settlement and mentioned: “This fruitful cooperation is geared toward supporting thalassemia sufferers within the UAE, and comes on account of our perception within the capabilities and medical experience accessible in Burjeel Medical City. Previously, sufferers had been despatched overseas to obtain therapy, via bone marrow transplantation for instance, however with the supply of those superior remedies in Burjeel Medical City – a supply of satisfaction for us all within the UAE, now we have a robust incentive to refer sufferers to this facility with the intention to relieve them of the burden of touring overseas.” 

John Sunil, Regional CEO of Burjeel Hospitals, mentioned that VPS Healthcare is pleased with this partnership, which displays confidence within the capabilities of the Group’s hospitals, and highlights its dedication to assuaging the struggling and ache of sufferers by providing them the most effective care, and the most recent world-class remedies at Burjeel Medical City. 

He added: “We are repeatedly engaged on growing our medical competencies with the intention to take care of thalassemia sufferers. This is a continual illness that the affected person should reside with. It requires a full staff to offer take care of sufferers, and fortunately now we have these competencies, applied sciences and fashionable remedies. But on the identical time, we want the management and help of the Foundation to learn from the intensive experiences they’ve on this subject, in addition to their data of the wants of sufferers inside the nation, to assist us present the providers which are wanted.” 

Dr. Khaled Musallam, the Group Chief Research Officer at VPS Healthcare, mentioned: “Thalassemia remedies proceed to evolve with notable advances seen globally year-on-year, and a substantial amount of analysis is now devoted to growing remedies that may assist alleviate the burden and problems of the illness, and enhance high quality of life. This new cooperation will help us in our ongoing efforts to collaborate with the worldwide analysis group and take part in innovative analysis that can enable us to grasp the wants of our sufferers and present superior remedies at an early stage.” 

For PR enquiries please contact
Acorn Strategy  
Maryam Danagege 
Email: [email protected]